The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-08-15

AUTHORS

Kyoung Hyun Yu, Hyewon Youn, Myung Geun Song, Dong Soo Lee, June-Key Chung

ABSTRACT

PurposeThe heat shock protein 90 inhibitor, tanespimycin, is an anticancer agent known to increase iodine accumulation in normal and cancerous thyroid cells. Iodine accumulation is regulated by membrane proteins such as sodium iodide symporter (NIS) and pendrin (PDS), and thus we attempted to characterize the effects of tanespimycin on those genes.MethodsCells were incubated with tanespimycin in order to evaluate 125I accumulation and efflux ability. Radioiodine uptake and efflux were measured by a gamma counter and normalized by protein amount. RT-PCR were performed to measure the level of gene expression.ResultsAfter tanespimycin treatment, 125I uptake was increased by ∼2.5-fold in FRTL-5, hNIS-ARO, and hNIS-MDA-MB-231 cells, but no changes were detected in the hNIS-HeLa cells. Tanespimycin significantly reduced the radioiodine efflux rate only in the FRTL-5 cells. In the FRTL-5 and hNIS-ARO cells, PDS mRNA levels were markedly reduced; the only other observed alteration in the levels of NIS mRNA after tanespimycin treatment was an observed increase in the hNIS-ARO cells.ConclusionsThese results indicate that cellular responses against tanespimycin treatment differed between the normal rat thyroid cells and human cancer cells, and the reduction in the 125I efflux rate by tanespimycin in the normal rat thyroid cells might be attributable to reduced PDS gene expression. More... »

PAGES

239-246

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13139-012-0158-4

DOI

http://dx.doi.org/10.1007/s13139-012-0158-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050890815

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24900070


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Tumor Biology, Seoul National University College of Medicine, Seoul, Korea", 
            "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Kyoung Hyun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Imaging Center, Seoul National University Cancer Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea", 
            "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
            "Cancer Imaging Center, Seoul National University Cancer Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Youn", 
        "givenName": "Hyewon", 
        "id": "sg:person.01226613531.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226613531.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Tumor Biology, Seoul National University College of Medicine, Seoul, Korea", 
            "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Song", 
        "givenName": "Myung Geun", 
        "id": "sg:person.01053723751.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053723751.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Science, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Science, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Tumor Biology, Seoul National University College of Medicine, Seoul, Korea", 
            "Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13139-009-0016-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025415769", 
          "https://doi.org/10.1007/s13139-009-0016-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051631971", 
          "https://doi.org/10.1007/s002800050817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/379458a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016268461", 
          "https://doi.org/10.1038/379458a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1021321409159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002829114", 
          "https://doi.org/10.1023/a:1021321409159"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-08-15", 
    "datePublishedReg": "2012-08-15", 
    "description": "PurposeThe heat shock protein 90 inhibitor, tanespimycin, is an anticancer agent known to increase iodine accumulation in normal and cancerous thyroid cells. Iodine accumulation is regulated by membrane proteins such as sodium iodide symporter (NIS) and pendrin (PDS), and thus we attempted to characterize the effects of tanespimycin on those genes.MethodsCells were incubated with tanespimycin in order to evaluate 125I accumulation and efflux ability. Radioiodine uptake and efflux were measured by a gamma counter and normalized by protein amount. RT-PCR were performed to measure the level of gene expression.ResultsAfter tanespimycin treatment, 125I uptake was increased by \u223c2.5-fold in FRTL-5, hNIS-ARO, and hNIS-MDA-MB-231 cells, but no changes were detected in the hNIS-HeLa cells. Tanespimycin significantly reduced the radioiodine efflux rate only in the FRTL-5 cells. In the FRTL-5 and hNIS-ARO cells, PDS mRNA levels were markedly reduced; the only other observed alteration in the levels of NIS mRNA after tanespimycin treatment was an observed increase in the hNIS-ARO cells.ConclusionsThese results indicate that cellular responses against tanespimycin treatment differed between the normal rat thyroid cells and human cancer cells, and the reduction in the 125I efflux rate by tanespimycin in the normal rat thyroid cells might be attributable to reduced PDS gene expression.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13139-012-0158-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1016285", 
        "issn": [
          "1869-3474", 
          "1869-3482"
        ], 
        "name": "Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "46"
      }
    ], 
    "keywords": [
      "normal rat thyroid cells", 
      "rat thyroid cells", 
      "gene expression", 
      "thyroid cells", 
      "PDS mRNA levels", 
      "FRTL-5", 
      "PDS gene expression", 
      "heat shock protein 90 inhibitor", 
      "shock protein 90 inhibitors", 
      "human cancer cells", 
      "membrane proteins", 
      "iodine accumulation", 
      "cellular responses", 
      "MB-231 cells", 
      "FRTL-5 cells", 
      "cancerous thyroid cells", 
      "protein amount", 
      "sodium iodide symporter", 
      "efflux rate", 
      "cancer cells", 
      "tanespimycin", 
      "efflux ability", 
      "expressing cells", 
      "mRNA levels", 
      "NIS mRNA", 
      "radioiodine accumulation", 
      "radioiodine uptake", 
      "RT-PCR", 
      "cells", 
      "accumulation", 
      "ConclusionsThese results", 
      "expression", 
      "gamma counter", 
      "observed alterations", 
      "anticancer agents", 
      "genes", 
      "treatment", 
      "symporter", 
      "protein", 
      "uptake", 
      "mRNA", 
      "pendrin", 
      "MethodsCells", 
      "efflux", 
      "inhibitors", 
      "levels", 
      "observed increase", 
      "alterations", 
      "rate", 
      "effect", 
      "agents", 
      "response", 
      "ability", 
      "increase", 
      "reduction", 
      "changes", 
      "amount", 
      "results", 
      "order", 
      "counter"
    ], 
    "name": "The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells", 
    "pagination": "239-246", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050890815"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13139-012-0158-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24900070"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13139-012-0158-4", 
      "https://app.dimensions.ai/details/publication/pub.1050890815"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_573.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13139-012-0158-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-012-0158-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-012-0158-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-012-0158-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-012-0158-4'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      21 PREDICATES      89 URIs      77 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13139-012-0158-4 schema:about anzsrc-for:06
2 anzsrc-for:0601
3 schema:author N8206bf5d509441eebd8c7a8da4c78c90
4 schema:citation sg:pub.10.1007/s002800050817
5 sg:pub.10.1007/s13139-009-0016-1
6 sg:pub.10.1023/a:1021321409159
7 sg:pub.10.1038/379458a0
8 schema:datePublished 2012-08-15
9 schema:datePublishedReg 2012-08-15
10 schema:description PurposeThe heat shock protein 90 inhibitor, tanespimycin, is an anticancer agent known to increase iodine accumulation in normal and cancerous thyroid cells. Iodine accumulation is regulated by membrane proteins such as sodium iodide symporter (NIS) and pendrin (PDS), and thus we attempted to characterize the effects of tanespimycin on those genes.MethodsCells were incubated with tanespimycin in order to evaluate 125I accumulation and efflux ability. Radioiodine uptake and efflux were measured by a gamma counter and normalized by protein amount. RT-PCR were performed to measure the level of gene expression.ResultsAfter tanespimycin treatment, 125I uptake was increased by ∼2.5-fold in FRTL-5, hNIS-ARO, and hNIS-MDA-MB-231 cells, but no changes were detected in the hNIS-HeLa cells. Tanespimycin significantly reduced the radioiodine efflux rate only in the FRTL-5 cells. In the FRTL-5 and hNIS-ARO cells, PDS mRNA levels were markedly reduced; the only other observed alteration in the levels of NIS mRNA after tanespimycin treatment was an observed increase in the hNIS-ARO cells.ConclusionsThese results indicate that cellular responses against tanespimycin treatment differed between the normal rat thyroid cells and human cancer cells, and the reduction in the 125I efflux rate by tanespimycin in the normal rat thyroid cells might be attributable to reduced PDS gene expression.
11 schema:genre article
12 schema:isAccessibleForFree true
13 schema:isPartOf N7732f4bd59c742e89586c62a784b3a6b
14 N845915a650804787ba06266f5326bf35
15 sg:journal.1016285
16 schema:keywords ConclusionsThese results
17 FRTL-5
18 FRTL-5 cells
19 MB-231 cells
20 MethodsCells
21 NIS mRNA
22 PDS gene expression
23 PDS mRNA levels
24 RT-PCR
25 ability
26 accumulation
27 agents
28 alterations
29 amount
30 anticancer agents
31 cancer cells
32 cancerous thyroid cells
33 cells
34 cellular responses
35 changes
36 counter
37 effect
38 efflux
39 efflux ability
40 efflux rate
41 expressing cells
42 expression
43 gamma counter
44 gene expression
45 genes
46 heat shock protein 90 inhibitor
47 human cancer cells
48 increase
49 inhibitors
50 iodine accumulation
51 levels
52 mRNA
53 mRNA levels
54 membrane proteins
55 normal rat thyroid cells
56 observed alterations
57 observed increase
58 order
59 pendrin
60 protein
61 protein amount
62 radioiodine accumulation
63 radioiodine uptake
64 rat thyroid cells
65 rate
66 reduction
67 response
68 results
69 shock protein 90 inhibitors
70 sodium iodide symporter
71 symporter
72 tanespimycin
73 thyroid cells
74 treatment
75 uptake
76 schema:name The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells
77 schema:pagination 239-246
78 schema:productId N27e636858d944c5883b5efc5ebb7f504
79 N2c5eea99ac3548cc84a1e7a8614e411b
80 Nc63160b4e78f47028c07940b191cb267
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050890815
82 https://doi.org/10.1007/s13139-012-0158-4
83 schema:sdDatePublished 2022-10-01T06:37
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Nd49b49c38fdb4413a91a6786b714f99f
86 schema:url https://doi.org/10.1007/s13139-012-0158-4
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N12a21c2efe01417c886d5e438df292dd schema:affiliation grid-institutes:grid.31501.36
91 schema:familyName Lee
92 schema:givenName Dong Soo
93 rdf:type schema:Person
94 N27e636858d944c5883b5efc5ebb7f504 schema:name pubmed_id
95 schema:value 24900070
96 rdf:type schema:PropertyValue
97 N2c5eea99ac3548cc84a1e7a8614e411b schema:name doi
98 schema:value 10.1007/s13139-012-0158-4
99 rdf:type schema:PropertyValue
100 N40cf08af02ef4b51acbd9a7e47c9a48a schema:affiliation grid-institutes:grid.31501.36
101 schema:familyName Yu
102 schema:givenName Kyoung Hyun
103 rdf:type schema:Person
104 N4347cf083af9499495d4652587bfcfcd rdf:first sg:person.01053723751.31
105 rdf:rest Nd269ee4b7f584573b8d90a8b7e6418b6
106 N46801208370d4b19911cb14edcbe175f rdf:first sg:person.0751347234.39
107 rdf:rest rdf:nil
108 N7732f4bd59c742e89586c62a784b3a6b schema:issueNumber 4
109 rdf:type schema:PublicationIssue
110 N8206bf5d509441eebd8c7a8da4c78c90 rdf:first N40cf08af02ef4b51acbd9a7e47c9a48a
111 rdf:rest Nc8c3189745a041019f1da7fa17118b32
112 N845915a650804787ba06266f5326bf35 schema:volumeNumber 46
113 rdf:type schema:PublicationVolume
114 Nc63160b4e78f47028c07940b191cb267 schema:name dimensions_id
115 schema:value pub.1050890815
116 rdf:type schema:PropertyValue
117 Nc8c3189745a041019f1da7fa17118b32 rdf:first sg:person.01226613531.96
118 rdf:rest N4347cf083af9499495d4652587bfcfcd
119 Nd269ee4b7f584573b8d90a8b7e6418b6 rdf:first N12a21c2efe01417c886d5e438df292dd
120 rdf:rest N46801208370d4b19911cb14edcbe175f
121 Nd49b49c38fdb4413a91a6786b714f99f schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
124 schema:name Biological Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
127 schema:name Biochemistry and Cell Biology
128 rdf:type schema:DefinedTerm
129 sg:journal.1016285 schema:issn 1869-3474
130 1869-3482
131 schema:name Nuclear Medicine and Molecular Imaging
132 schema:publisher Springer Nature
133 rdf:type schema:Periodical
134 sg:person.01053723751.31 schema:affiliation grid-institutes:grid.31501.36
135 schema:familyName Song
136 schema:givenName Myung Geun
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053723751.31
138 rdf:type schema:Person
139 sg:person.01226613531.96 schema:affiliation grid-institutes:grid.412484.f
140 schema:familyName Youn
141 schema:givenName Hyewon
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226613531.96
143 rdf:type schema:Person
144 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
145 schema:familyName Chung
146 schema:givenName June-Key
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
148 rdf:type schema:Person
149 sg:pub.10.1007/s002800050817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051631971
150 https://doi.org/10.1007/s002800050817
151 rdf:type schema:CreativeWork
152 sg:pub.10.1007/s13139-009-0016-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025415769
153 https://doi.org/10.1007/s13139-009-0016-1
154 rdf:type schema:CreativeWork
155 sg:pub.10.1023/a:1021321409159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002829114
156 https://doi.org/10.1023/a:1021321409159
157 rdf:type schema:CreativeWork
158 sg:pub.10.1038/379458a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016268461
159 https://doi.org/10.1038/379458a0
160 rdf:type schema:CreativeWork
161 grid-institutes:grid.31501.36 schema:alternateName Department of Molecular Medicine and Biopharmaceutical Science, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
162 Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
163 schema:name Department of Molecular Medicine and Biopharmaceutical Science, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
164 Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea
165 Department of Tumor Biology, Seoul National University College of Medicine, Seoul, Korea
166 Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
167 rdf:type schema:Organization
168 grid-institutes:grid.412484.f schema:alternateName Cancer Imaging Center, Seoul National University Cancer Hospital, Seoul, Korea
169 schema:name Cancer Imaging Center, Seoul National University Cancer Hospital, Seoul, Korea
170 Department of Nuclear Medicine, Seoul National University College of Medicine, #207-4, Samsung Cancer Research Building, 28 Yeongeon-dong, Jongno-gu, 110-744, Seoul, Korea
171 Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...